IMPROVE-IT: 'Modest' Benefit With Ezetimibe in Post-ACS PatientsIMPROVE-IT: 'Modest' Benefit With Ezetimibe in Post-ACS Patients

It's taken 9 years to learn whether or not adding ezetimibe to statins provide any clinical benefit in post-ACS patients. The answer: yes, it does, but the benefit is modest. What this means in the real world will likely be debated for many months to come. Heartwire
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news